SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: June 3, 2004
CANTEL MEDICAL CORP.
(Exact name of registrant as specified in its Charter)
Delaware | | 001-31337 | | 22-1760285 |
(State or other jurisdiction
of incorporation) | | (Commission
File Number) | | (IRS Identification
Number) |
| | | | |
150 Clove Road, Little Falls, New Jersey | | 07424 |
(Address of principal executive offices) | | (Zip Code) |
|
Registrant’s telephone number, including area code: (973) 890-7220 |
|
|
(Former name or former address, if changed since last report) |
Item 12. Results of Operations and Financial Condition
On June 3, 2004, the Registrant issued a press release announcing its results of operations for the quarter ended April 30, 2004. A copy of the press release is included with this Report as Exhibit 99(l).
Item 7. Financial Statements, Pro-Forma Financial Information and Exhibits
(c) Exhibit 99(l). Press release of Cantel Medical Corp. dated June 3, 2004.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CANTEL MEDICAL CORP. |
| |
| |
| By: | /s/ James P. Reilly | |
| James P. Reilly, |
| President and Chief Executive Officer |
| |
Dated: June 4, 2004 | |
3
